Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan
- 361 Downloads
Background Many trials have compared anticoagulation management provided by a pharmacist led anticoagulation clinic versus usual physician care showing the role for clinical pharmacist in the management of anticoagulant therapy, and demonstrating excellent outcomes. In Sudan, there is no published research evaluating the role of pharmacist in providing pharmaceutical care for patients taking warfarin. Objective The objective of the study is to assess the role of clinical pharmacist intervention in warfarin patients compared to usual medical care. Setting This study was conducted in Ahmed Gasim cardiac surgery and renal transplant center warfarin clinic. Methods One hundred thirty-five patients were randomly selected from adult patients on warfarin therapy The history of INR records, and adverse effects for the past year, were recorded. Then patients’ warfarin dose adjustments according to INR, was done by the clinical pharmacist for one year. Patients received continuous verbal education and written information about warfarin. Main outcome measure The primary outcome for this study was the INR control, while the secondary outcomes were the bleeding events and hospitalization due to warfarin. Results After the clinical pharmacist intervention there was significant (P < 0.01) improvement in INR control and a significant (P < 0.05) reduction in incidence of bleeding after clinical pharmacist intervention. Hospitalization due to warfarin related complications (bleeding, high INR, low INR) was also significantly (P < 0.001) reduced. Conclusion Clinical pharmacists intervention in warfarin therapy improve INR control, reduce bleeding and hospitalization due to warfarin complications.
KeywordsAnticoagulation Clinical pharmacist Intervention Sudan
We would like to show our gratitude to the patients who agreed to participate in this study, and to the center laboratory staff for their cooperation and patience.
There was no specific funding received for this research.
Conflicts of interest
Authors declare that they have no conflict of interest.
- 1.Koda-Kimble MA, Young YL, Alldredge BK, Corelli RL, Guglielmo BJ, Kradjan WA et al. Applied therapeutics: the clinical use of drugs. 9th ed. USA, Lippincott Williams & Wilkins. 2009. P. 15/2-15/34. ISBN 978-0-7817-6555-8.Google Scholar
- 2.Chicholm-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, Rotschafer JC et al. Pharmacotherapy principles and practice. New York: McGraw-Hill Companies. 2008. p.133-160. ISBN 0-07-150977-1.Google Scholar
- 3.Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy Apathophysiologic Approach. 7th ed. New York:McGraw-Hill Companies. 2008. p. 331-372. ISBN 0-07-164325-7.Google Scholar
- 6.Dipiro JT. Anticoagulation clinical pharmacy practice, In: Patricia HS, editor. Encyclopedia of clinical pharmacy. (e-book): USA, Marcel Dekker; 2003. p 63–70. ISBN-10: 0824707524.Google Scholar
- 7.Damaske DL, Baird RW. Development and implementation of a pharmacist-managed inpatient warfarin protocol. Baylor Univ Med Center Proc. 2005;18(4):397–400.Google Scholar
- 12.Young S, Bishop L, Twells L, Dillon C, Hawboldt J, O’Shea P. Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic, BMC family practice. 2011; 12:88 (e-journal). http://bmcfampract.biomedcentral.com/articles/10.1186/1471-2296-12-88. Accessed December 5 2016.
- 15.Anila KN, Emmanuel J. Study on impact of clinical pharmacist improving knowledge of cardiology out- patients about oral anticoagulant. Indian J Pharm Pract. 2013;6(1):31–5.Google Scholar
- 17.Ernst ME, Brandt KB. Evaluation of 4 years of clinical pharmacist anticoagulation case management in a rural, private physician office. J Am Pharm Assoc. 2003;43(5):630–636.Google Scholar